Stocks TelegraphStocks Telegraph
Stock Ideas

AADI Financial Statements and Analysis

NASDAQ : AADI

Aadi Bioscience

$2.05
-0.05-2.38%
At Close 4:00 PM
Not Actively Trading
60.9
BESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202520252025
periodQ2Q1Q3Q2Q1
revenue00007.145M
cost of revenue005.00K0760.00K
gross profit00-5.00K06.385M
gross profit ratio00000.894
research and development expenses12.893M17.232M14.345M48.809M8.788M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses5.216M6.29M5.196M5.94M12.815M
other expenses00000
operating expenses18.109M23.522M19.541M54.749M21.603M
cost and expenses18.109M23.522M19.546M54.749M22.363M
interest income1.475M1.328M1.85M1.979M791.00K
interest expense00000
depreciation and amortization1.00K05.00K16.00K48.25K
ebitda-18.108M-22.194M-17.741M-52.599M-15.17M
ebitda ratio0000-2.123
operating income-18.109M-23.522M-19.546M-54.749M-15.218M
operating income ratio0000-2.13
total other income expenses net1.469M1.328M1.80M2.134M88.234M
income before tax-16.64M-22.194M-17.746M-52.615M73.016M
income before tax ratio000010.219
income tax expense00000
net income-16.64M-22.194M-17.746M-52.615M73.016M
net income ratio000010.219
eps-0.20-0.32-0.26-0.761.84
eps diluted-0.20-0.32-0.26-0.761.83
weighted average shs out82.886M69.237M68.254M69.083M27.087M
weighted average shs out dil82.886M69.237M69.205M69.083M27.087M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202520252025
periodQ2Q1Q3Q2Q1
cash and cash equivalents85.234M34.79M37.931M144.936M227.569M
short term investments104.748M88.253M124.666M32.264M3.493M
cash and short term investments189.982M123.043M162.597M177.20M231.062M
net receivables00000
inventory00000
other current assets2.432M2.505M2.439M1.471M1.552M
total current assets192.414M125.548M165.036M178.671M232.614M
property plant equipment net1.00K2.00K4.00K9.00K25.00K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets1.579M1.681M1.977M2.142M1.363M
total non current assets1.58M1.683M1.981M2.151M1.388M
other assets00000
total assets193.994M127.231M167.017M180.822M234.002M
account payables1.105M1.745M1.633M3.339M3.657M
short term debt00000
tax payables00000
deferred revenue00000
other current liabilities9.964M9.311M8.216M5.417M8.617M
total current liabilities11.069M11.056M9.849M8.756M12.274M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities00000
other liabilities00000
capital lease obligations00000
total liabilities11.069M11.056M9.849M8.756M12.274M
preferred stock00000
common stock5.00K4.00K4.00K4.00K4.00K
retained earnings-392.084M-375.444M-329.999M-312.253M-259.638M
accumulated other comprehensive income loss-63.00K-15.00K139.00K9.00K1.00K
other total stockholders equity575.067M491.63M487.024M484.306M481.361M
total stockholders equity182.925M116.175M157.168M172.066M221.728M
total equity182.925M116.175M157.168M172.066M221.728M
total liabilities and stockholders equity193.994M127.231M167.017M180.822M234.002M
minority interest00000
total investments104.748M88.253M124.666M32.264M3.493M
total debt00000
net debt-85.234M-34.79M-37.931M-144.936M-227.569M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025Sep 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202520252024
periodQ2Q1Q2Q1Q3
deferred income tax00000
stock based compensation1.52M2.193M3.087M1.68M9.097M
change in working capital949.00K1.633M-3.447M733.00K0
accounts receivables000-1.00M-1.052M
inventory000170.00K958.00K
accounts payables0000-10.365M
other working capital949.00K1.633M-3.447M1.563M0
other non cash items-359.00K-3.841M2.00K-87.35M-19.716M
net cash provided by operating activities-14.529M-22.208M-52.957M-11.864M-22.75M
investments in property plant and equipment00-1.00K-551.00K2.266M
acquisitions net000101.356M0
purchases of investments-50.635M-19.186M-32.215M0-36.483M
sales maturities of investments33.768M38.616M3.39M14.693M50.02M
other investing activites00000
net cash used for investing activites-16.867M19.43M-28.826M115.498M15.803M
debt repayment00000
common stock issued87.584M0-850.00K100.002M0
common stock repurchased000094.00K
dividends paid00000
other financing activites-5.744M00-4.801M-24.454M
net cash used provided by financing activities81.84M0-850.00K95.201M-24.36M
effect of forex changes on cash00000
net change in cash50.444M-2.778M-82.633M198.835M819.00K
cash at end of period85.234M34.79M144.936M227.569M30.601M
cash at beginning of period34.79M37.568M227.569M28.734M29.782M
operating cashflow-14.529M-22.208M-52.957M-11.864M-22.75M
capital expenditure00-1.00K-551.00K2.266M
free cash flow-14.529M-22.208M-52.958M-12.415M-20.484M
Graph

Frequently Asked Questions

How did Aadi Bioscience, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, AADI generated $0.00 in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Aadi Bioscience, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Aadi Bioscience, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2026.
Have AADI's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. AADI incurred $18.11M worth of Operating Expenses, while it generated -$18.11M worth of Operating Income.
How much Net Income has AADI posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Aadi Bioscience, Inc., the company generated -$16.64M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Aadi Bioscience, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Aadi Bioscience, Inc. as of the end of the last quarter was $85.23M.
What are AADI's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, AADI had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did Aadi Bioscience, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of AADI were $192.41M, while the Total Assets stand at $193.99M.
As of the last quarter, how much Total Debt did Aadi Bioscience, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of AADI's debt was $0.00 at the end of the last quarter.
What were AADI's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, AADI reported total liabilities of $11.07M.
How much did AADI's Working Capital change over the last quarter?
Working Capital Change for AADI was $949.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
AADI generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. AADI generated -$14.53M of Cash from Operating Activities during its recently reported quarter.
What was AADI's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. AADI reported a $50.44M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph